Cargando…
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
Background: Duloxetine hydrochloride (DUL) is an antidepressant included in the pharmacological class of serotonin–norepinephrine reuptake inhibitors approved for the treatment of major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic...
Autores principales: | Muscatello, Maria Rosaria Anna, Zoccali, Rocco A., Pandolfo, Gianluca, Mangano, Paolo, Lorusso, Simona, Cedro, Clemente, Battaglia, Fortunato, Spina, Edoardo, Bruno, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844294/ https://www.ncbi.nlm.nih.gov/pubmed/31749717 http://dx.doi.org/10.3389/fpsyt.2019.00772 |
Ejemplares similares
-
Impulsivity and Metacognition in a Psychiatric Population
por: Turiaco, Fabrizio, et al.
Publicado: (2022) -
Lifetime Psychiatric Comorbidity and Diagnostic Trajectories in an Italian Psychiatric Sample
por: Bruno, Antonio, et al.
Publicado: (2020) -
Low-Dose of Bergamot-Derived Polyphenolic Fraction (BPF) Did Not Improve Metabolic Parameters in Second Generation Antipsychotics-Treated Patients: Results from a 60-days Open-Label Study
por: Bruno, Antonio, et al.
Publicado: (2017) -
Emerging treatments in the management of schizophrenia – focus on sertindole
por: Muscatello, Maria Rosaria A, et al.
Publicado: (2010) -
The Relationship between Alexithymia, Anxiety, Depression, and Internet Addiction Severity in a Sample of Italian High School Students
por: Scimeca, Giuseppe, et al.
Publicado: (2014)